Johnson & Johnson is manufacturing Tylenol at maximum capacity to meet demand from the coronavirus. Demand for Tylenol rose two to four times over normal levels in the last three weeks, J&J said. (Reuters)

COVID-19 messaging from the Centers for Disease Control and Prevention is being overshadowed by White House statements. Leaders from the CDC have not appeared at White House coronavirus briefings for more than a week. (Washington Post)

Roche will test rheumatoid arthritis drug Acterma in COVID-19 patients. The company will run a phase 3 trial of the drug in COVID-19 patients that have been hospitalized with severe pneumonia. The trial will enroll up to 300 participants in April. (MarketWatch)

The Food and Drug Administration has suspended vape shop inspections. Employees are being urged to work remote and many other inspections, both foreign and in the U.S., have been postponed until April. (Reuters)

Bayer has donated three million tablets of Resochin, its anti-malarial drug, to the U.S. government to treat COVID-19 patients. The drug has not been approved to treat these patients, but early studies show it may be effective. (MarketWatch)